Annals of the Forum for
Collaborative HIV Research
Click here to return to the archive.
Contact Information
Mailing Address
The Forum for Collaborative Research
1608 Rhode Island Avenue NW, Suite 212
Washington, DC 20036
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Editorial Focus and Scope
Annals of the Forum for Collaborative HIV Research (ISSN: 2155-790X) is a peer-reviewed, online academic journal, published 2-4 times a year. The aim of Annals is to shed light and offer solutions to emerging and complex scientific issues that have stalled research on HIV prevention and treatment and HCV drug development, thereby contributing to improved health outcomes. The goal of Annals is to publish and widely disseminate the work of the Forum for Collaborative Research and its members. Annals publishes high-quality consensus reports and proceedings, as well as policy briefs produced by Forum members addressing current topics in HIV/AIDS prevention, treatment and care, and HCV drug development.
The Forum brings together experts and stakeholders including researchers, advocates, national and international agencies, pharmaceutical and diagnostic companies, health care providers and private foundations to discuss and advance the HIV and HCV research agendas since 1997. One of the primary objectives of Annals is to highlight the consensus reached on major research gaps in HIV prevention, care and treatment, and HCV drug development. The views of all stakeholders on these important issues helps advance the research agenda and drives public policy, consequently improving the lives of people affected by HIV/AIDS and HCV.
Annals provides its readership free online access to all of its content.
Policies
Peer Review Process
The Editors will assemble an Editorial Board, whose membership includes subject area experts willing to act as potential reviewers and who would have agreed in advance to serve the journal.
Initial Manuscript Evaluation
Annals only accepts commissioned manuscripts from Forum members- stakeholders from government, industry, advocates, healthcare providers, foundations, health insurers and academia- for publication.
Policy of Peer Review
Annals does not employ blinding of either reviewer or reviewee.
Reviewer Evaluation
After initial evaluation, the manuscript is sent to two Editorial Board members who are determined by the editor according to their expertise. Reviewers are asked to evaluate the manuscript for accuracy, support for the conclusions, appropriateness of recommendations and bibliography. Reviewers may recommend acceptance of the manuscript or may recommend revisions for style and/or content. Reviewers have 30 days to review a manuscript. When a revision is required, the author(s) are to consider the comments offered by the reviewers, and should send back the revised version of the manuscript in 30 days. This should be accompanied by a letter detailing the changes made, as well as an explanation for changes not made. Reviewers may request more than one revision of a manuscript.
Final Evaluation
After final favorable review, the Editors make the final decision regarding publication of articles.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Disclosure of Conflict-Of-Interest
Authors should disclose all potential conflicts of interest, including relevant financial interests, activities, relationships, and affiliations (other than those affiliations listed in the title page of the manuscript), including: any potential conflicts of interest involving the work under consideration for publication (during the time involving the work, from initial conception and planning to present); any relevant financial activities outside the submitted work (over the 3 years prior to submission), and any other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing what is written in the submitted work (based on all relationships that were present during the 3 years prior to submission).
Published Statement of Informed Consent
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.
Published Statement of Human and Animal Rights
Humans: When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Animals: When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
